Novartis Vaccines and Diagnostics, Inc. et al v. Bayer Healthcare, LLC et al, No. 2:08-cv-00068 (E.D. Tex. Sept. 28, 2009)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Before the court is Defendants Bayer HealthCare LLC’s (“Bayer”) and CSL Behring LLC’s (“CSL”) (collectively “Defendants”) Motion to Transfer Venue to the Northern District of California. [Dkt. No. 23] Defendants request th at this case be transferred to the Northern District of California (“NDCA”) pursuant to 28 U.S.C. § 1404(a) and Fed. R. Civ. P. 20 and 21. After careful consideration of the parties’ written submissions, Defendants’ motion is DENIED for the reasons set forth in this opinion. I.